Monopar Therapeutics (MNPR) Share-based Compensation (QoQ) (2017 - 2025)
Monopar Therapeutics (MNPR) Share-based Compensation (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -140.03% |
| Sep 30, 2025 | -2.27% |
| Jun 30, 2025 | -10.20% |
| Mar 31, 2025 | 117.06% |
| Dec 31, 2024 | 2,997.48% |
| Sep 30, 2024 | -19.51% |
| Jun 30, 2024 | -44.90% |
| Mar 31, 2024 | 123.09% |
| Dec 31, 2023 | -729.78% |
| Sep 30, 2023 | -25.91% |
| Jun 30, 2023 | 36.64% |
| Mar 31, 2023 | -43.25% |
| Dec 31, 2022 | 91.54% |
| Sep 30, 2022 | 34.60% |
| Jun 30, 2022 | -69.47% |
| Mar 31, 2022 | 42.74% |
| Dec 31, 2021 | -10.69% |
| Sep 30, 2021 | 9.64% |
| Jun 30, 2021 | -2.89% |
| Mar 31, 2021 | -10.79% |